Stay updated on Palbociclib in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib in Metastatic Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T03:48:14.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to HER-2 positive breast cancer treatments, specifically listing letrozole, anastrozole, exemestane, and fulvestrant, while significant details about a previous study involving palbociclib have been removed.
    Difference
    21%
    Check dated 2025-04-16T14:23:52.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 13, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.2%
    Check dated 2025-04-09T09:12:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new company name, GBG Forschungs GmbH, replacing the previous name, German Breast Group. Additionally, the last update date has changed from January 13, 2025, to March 25, 2025, indicating a more recent revision.
    Difference
    0.2%
    Check dated 2025-04-01T23:18:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-24T21:11:19.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-10T10:05:11.000Z thumbnail image

Stay in the know with updates to Palbociclib in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.